Study: COVID Shot Enhances Delta Infectivity
Analysis by Dr. Joseph Mercola / September 6, 2021
Excerpts from the article:
- According to the U.S. Centers for Disease Control and Prevention, people who got the COVID shot early are now at increased risk for severe COVID disease
- This may be a sign that antibody dependent enhancement (ADE) is occurring, or it may simply indicate that the protection offered is limited to a few months, at best
- Recent research warns the Delta variant “is posed to acquire complete resistance to wild-type spike vaccines.” This could turn into a worst-case scenario that sets up those who have received the Pfizer shots for more severe illness when exposed to the virus
- To “stay ahead of the virus,” the Biden administration is now considering recommending a booster shot five months after the initial two doses rather than waiting eight months, as previously suggested
- Israeli data show Pfizer’s shot went from a 95% effectiveness at the outset to 39% by late July 2021, when the Delta strain became predominant. The U.S. Food and Drug Administration’s expectation for any vaccine is an efficacy rate of at least 50% compared to placebo
Data from the U.K. show a similar trend among those over the age of 50. In this age group, partially and fully “vaccinated” people account for 68% of hospitalizations and 70% of COVID deaths.
It’s now clear that early warnings against mass vaccination during an active outbreak are being realized. It’s not the unvaccinated that are driving mutations; it’s the vaccinated, as the injections simply do not prevent infection.
Categories: National News